Under construction – not a live service
Sign in
Taking people in ItalyNo phase

Comparing Lung Ultrasound With CT Scans in People With Emphysema

Compares lung ultrasound patterns with CT scan findings in adults with emphysema.

Plain-language title generated from the registry record
Registry title: Clinical-ultrasonographic Assessment of Pulmonary Emphysema

Key facts

Where
Acquaviva Delle Fonti, Naples, Rome, and Trento, ItalySee the 4 sites

Where in Italy

  • Ente Ecclesiastico Ospedale Generale Regionale F MiulliAcquaviva Delle Fonti, ItalyNot yet recruiting
  • A.O.R.N. "A. Cardarelli"Naples, ItalyNot yet recruiting
  • Fondazione Policlinico Universitario A. Gemelli IRCCSRome, ItalyTaking people
  • University of TrentoTrento, ItalyNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Trial code
NCT06533371
Record updated
22 May 2026
Original description
The goal of this clinical trial is to identify correlations among data deriving from lung ultrasonographic (LUS) and tomographic evaluations of patients with panlobular or paraseptal emphysema, to improve the comprehension of acoustic information derived from ultrasound evaluation.Read full original descriptionShow less

Assessment of Pulmonary EmphySema: the Clinical -ULtrasonographic APproach to chronIc Obstructive Pulmonary Disease

The goal of this clinical trial is to identify correlations among data deriving from lung ultrasonographic (LUS) and tomographic evaluations of patients with panlobular or paraseptal emphysema, to improve the comprehension of acoustic information derived from ultrasound evaluation.

The main question it aims to answer is: what are the correlations between thoracic ultrasonographic patterns and peripheral parenchymal changes evaluated by high resolution computed tomography (HRCT) of the chest, in patients affected with variable degree of panlobular or paraseptal emphysema? Researchers will compare LUS patterns observed in: 1) COPD patients with CT evidence of panlobular or paraseptal emphysema, 2) subjects participating in the screening program for lung cancer with CT evidence of panlobular or paraseptal emphysema, and 3) patients with suspected/known lung cancer undergoing with CT evidence of panlobular or paraseptal emphysema, with the ones obtained from healthy volunteers and subjects who participate in the screening program for lung cancer with no evidence of emphysema.

Participants will undergo LUS evaluation with both clinical and research scanners. Patients will be assessed in supine position with the arms extended above the head. The position is the same in which chest CT scans will be performed. LUS assessment will be performed using commercially available linear probes.

Finally, all COPD patients and subjects who participate in the screening program for lung cancer with CT evidence of paraseptal or panlobular emphysema will undergo respiratory oscillometry. Tidal breathing analysis with impulse oscillometry (IOS) has proven to be an informative and meaningful tool used in the early detection and follow up of pulmonary diseases like COPD.

Inclusion: outpatients in follow-up for chronic obstructive pulmonary disease, in stable conditions, with computed tomographic evidence of panlobular or paraseptal emphysema; Inpatients, admitted to the hospital due to acute exacerbation of chronic obstructive pulmonary disease, with computed tomographic evidence of panlobular or paraseptal emphysema; Subjects who participate in the screening program for lung cancer with computed tomographic evidence of panlobular or paraseptal emphysema; Outpatients / Inpatients with suspected/known lung cancer and computed tomographic evidence of panlobular or paraseptal emphysema; Patients able to give written informed consent.

Exclusion: pregnancy; Pediatric population; Patients unable to express written informed consent.

ClinicalTrials.gov NCT06533371